Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2 S Rost, A Fregin, V Ivaskevicius, E Conzelmann, K Hörtnagel, HJ Pelz, ... Nature 427 (6974), 537-541, 2004 | 1490 | 2004 |
Essential role of the C5a receptor in E coli–induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation TE Mollnes, OL Brekke, M Fung, H Fure, D Christiansen, G Bergseth, ... Blood, The Journal of the American Society of Hematology 100 (5), 1869-1877, 2002 | 569 | 2002 |
Cholesterol crystals induce complement-dependent inflammasome activation and cytokine release EO Samstad, N Niyonzima, S Nymo, MH Aune, L Ryan, SS Bakke, ... The Journal of Immunology 192 (6), 2837-2845, 2014 | 279 | 2014 |
Exercise reduces plasma levels of the chemokines MCP-1 and IL-8 in subjects with the metabolic syndrome M Trøseid, KT Lappegård, T Claudi, JK Damås, L Mørkrid, R Brendberg, ... European heart journal 25 (4), 349-355, 2004 | 247 | 2004 |
Plasma lipopolysaccharide is closely associated with glycemic control and abdominal obesity: evidence from bariatric surgery M Trøseid, TK Nestvold, K Rudi, H Thoresen, EW Nielsen, KT Lappegård Diabetes care 36 (11), 3627-3632, 2013 | 206 | 2013 |
Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo … DL Bhatt, PG Steg, SR Mehta, LA Leiter, T Simon, K Fox, C Held, ... The Lancet 394 (10204), 1169-1180, 2019 | 204 | 2019 |
Delayed leukocytosis and cytokine response to high-force eccentric exercise G Paulsen, HB Benestad, I Strøm-Gundersen, L Mørkrid, KT Lappegård, ... Medicine & Science in Sports & Exercise 37 (11), 1877-1883, 2005 | 176 | 2005 |
The effect of exercise on serum levels of interleukin-18 and components of the metabolic syndrome M Trøseid, KT Lappegård, TE Mollnes, H Arnesen, I Seljeflot Metabolic syndrome and related disorders 7 (6), 579-584, 2009 | 148 | 2009 |
Human genetic deficiencies reveal the roles of complement in the inflammatory network: lessons from nature KT Lappegård, D Christiansen, A Pharo, EB Thorgersen, BC Hellerud, ... Proceedings of the National Academy of Sciences 106 (37), 15861-15866, 2009 | 146 | 2009 |
The complement system and toll-like receptors as integrated players in the pathophysiology of atherosclerosis A Hovland, L Jonasson, P Garred, A Yndestad, P Aukrust, KT Lappegård, ... Atherosclerosis 241 (2), 480-494, 2015 | 133 | 2015 |
Delayed leukocytosis after hard strength and endurance exercise: aspects of regulatory mechanisms BA Risøy, T Raastad, J Hallén, KT Lappegård, K Bæverfjord, A Kravdal, ... BMC physiology 3, 1-12, 2003 | 99 | 2003 |
Effect of complement inhibition and heparin coating on artificial surface–induced leukocyte and platelet activation KT Lappegård, M Fung, G Bergseth, J Riesenfeld, JD Lambris, V Videm, ... The Annals of thoracic surgery 77 (3), 932-941, 2004 | 95 | 2004 |
Complement activation in patients with congestive heart failure: effect of high-dose intravenous immunoglobulin treatment P Aukrust, L Gullestad, KT Lappegård, T Ueland, H Aass, L Wikeby, ... Circulation 104 (13), 1494-1500, 2001 | 94 | 2001 |
Major increase in microbiota-dependent proatherogenic metabolite TMAO one year after bariatric surgery M Trøseid, JR Hov, TK Nestvold, H Thoresen, RK Berge, A Svardal, ... Metabolic syndrome and related disorders 14 (4), 197-201, 2016 | 80 | 2016 |
A vital role for complement in heart disease KT Lappegård, P Garred, L Jonasson, T Espevik, P Aukrust, A Yndestad, ... Molecular Immunology 61 (2), 126-134, 2014 | 72 | 2014 |
Artificial surface-induced cytokine synthesis: effect of heparin coating and complement inhibition KT Lappegård, M Fung, G Bergseth, J Riesenfeld, TE Mollnes The Annals of thoracic surgery 78 (1), 38-44, 2004 | 69 | 2004 |
Anti‐inflammatory effect of cardiac resynchronization therapy KT LappegÅRd, H Bjørnstad Pacing and clinical electrophysiology 29 (7), 753-758, 2006 | 65 | 2006 |
The artificial surface‐induced whole blood inflammatory reaction revealed by increases in a series of chemokines and growth factors is largely complement dependent KT Lappegård, G Bergseth, J Riesenfeld, A Pharo, P Magotti, JD Lambris, ... Journal of Biomedical Materials Research Part A: An Official Journal of The …, 2008 | 61 | 2008 |
Design of the GutHeart—targeting gut microbiota to treat heart failure—trial: a Phase II, randomized clinical trial CCK Mayerhofer, AO Awoyemi, SD Moscavitch, KT Lappegård, JR Hov, ... ESC Heart Failure 5 (5), 977-984, 2018 | 53 | 2018 |
Improved neurocognitive functions correlate with reduced inflammatory burden in atrial fibrillation patients treated with intensive cholesterol lowering therapy KT Lappegård, M Pop-Purceleanu, W van Heerde, J Sexton, I Tendolkar, ... Journal of neuroinflammation 10, 1-6, 2013 | 51 | 2013 |